| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 233.20B | 193.37B | 185.97B | 177.19B | 169.52B | 163.02B |
| Gross Profit | 80.26B | 64.72B | 62.55B | 60.12B | 57.69B | 57.94B |
| EBITDA | 16.48B | 11.66B | 13.76B | 13.36B | 12.38B | 13.75B |
| Net Income | 9.71B | 6.85B | 8.20B | 8.20B | 7.64B | 8.50B |
Balance Sheet | ||||||
| Total Assets | 159.12B | 160.25B | 149.82B | 141.34B | 129.90B | 122.86B |
| Cash, Cash Equivalents and Short-Term Investments | 72.23B | 72.49B | 67.83B | 63.06B | 59.22B | 60.92B |
| Total Debt | 1.63B | 247.00M | 1.15B | 563.00M | 1.09B | 830.00M |
| Total Liabilities | 62.96B | 61.58B | 58.55B | 56.35B | 52.80B | 50.56B |
| Stockholders Equity | 96.16B | 98.67B | 91.27B | 84.98B | 77.10B | 72.30B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.07B | 6.78B | 8.24B | 918.00M | 7.00B |
| Operating Cash Flow | 0.00 | 10.65B | 9.13B | 11.54B | 3.47B | 8.75B |
| Investing Cash Flow | 0.00 | -2.56B | -1.83B | -4.50B | -2.41B | -1.35B |
| Financing Cash Flow | 0.00 | -2.67B | -2.44B | -2.18B | -2.97B | -4.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥126.53B | 10.89 | ― | 2.23% | 9.57% | 33.85% | |
73 Outperform | ¥129.77B | -173.58 | ― | 1.54% | 4.78% | 3.50% | |
71 Outperform | ¥86.05B | 5.42 | 6.96% | 2.98% | 1.15% | 86.72% | |
65 Neutral | ¥207.85B | 40.03 | ― | 0.64% | 57.01% | 91.03% | |
64 Neutral | ¥77.66B | 10.29 | ― | 2.11% | 6.04% | 93.19% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥45.32B | 15.79 | ― | 3.31% | 0.88% | -138.66% |